The nation of Zimbabwe has turned down a significant American health deal worth $367m (£272m) spanning five years over the United States' insistence on sensitive biological samples.
This move came to light following a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government representative later explained that the US was requesting health data for research and profit but was not willing to share the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued dialogue to reach a deal agreeable to both sides so the nation's critical HIV treatment initiative can proceed.
Wider Implications
This development comes after a comparable case in neighbouring Kenya, where a court suspended a similar health funding agreement after legal challenges were filed about the safety of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance openness and accountability.
Based on reports, 16 nations in Africa have so far signed similar agreements, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information for a long time, with no equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"Put simply, our country would supply the raw materials for medical research without any assurance that the final treatments would be accessible to our people if a new health crisis arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems previously set up through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This system is intended to guarantee that when a country contributes its information, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to develop them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our American counterparts on how subsequent collaboration might be structured in a way that honours the independence and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but urged that negotiations need to persist since much of the nation's Aids initiatives depended on foreign aid.
"In cases where technical issues arise, such as those relating to data governance or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," it added.
This impasse highlights the complex tensions between receiving vital international aid and protecting local interests in an ever more interconnected world.